GoodRx Holdings, Inc. (GDRX)
GDRX Stock Price Chart
Explore GoodRx Holdings, Inc. interactive price chart. Choose custom timeframes to analyze GDRX price movements and trends.
GDRX Company Profile
Discover essential business fundamentals and corporate details for GoodRx Holdings, Inc. (GDRX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
23 Sept 2020
Employees
738.00
Website
https://www.goodrx.comCEO
Wendy Barnes
Description
GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform dedicated to price comparison, delivering customized, geographically tailored prescription pricing. It also grants access to special, negotiated rates through unique GoodRx codes, which can be utilized for savings on prescriptions throughout the entire United States. Beyond this core offering, the firm also extends its portfolio to include subscription services, programs designed for pharmaceutical manufacturers, and telehealth capabilities. GoodRx additionally collaborates with pharmacy benefit managers, entities responsible for managing drug formularies and overseeing prescription transactions, including the critical task of setting prices between consumers and pharmacies. The company was founded in 2015 and maintains its principal office in Santa Monica, California.
GDRX Financial Timeline
Browse a chronological timeline of GoodRx Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Aug 2026
EPS estimate is $0.08, while revenue estimate is $193.19m.
Earnings released on 6 May 2026
EPS came in at $0.07 matching the estimated $0.07, while revenue for the quarter reached $194.01m , beating expectations by +4.64%.
Earnings released on 25 Feb 2026
EPS came in at $0.09 matching the estimated $0.09, while revenue for the quarter reached $194.79m , beating expectations by +0.78%.
Earnings released on 4 Nov 2025
EPS came in at $0.08 falling short of the estimated $0.09 by -11.11%, while revenue for the quarter reached $196.03m , beating expectations by +1.43%.
Earnings released on 6 Aug 2025
EPS came in at $0.09 falling short of the estimated $0.10 by -10.00%, while revenue for the quarter reached $203.07m , missing expectations by -1.06%.
Earnings released on 7 May 2025
EPS came in at $0.09 matching the estimated $0.09, while revenue for the quarter reached $202.97m , beating expectations by +0.38%.
Earnings released on 27 Feb 2025
EPS came in at $0.09 falling short of the estimated $0.10 by -10.00%, while revenue for the quarter reached $198.58m , missing expectations by -0.58%.
Earnings released on 7 Nov 2024
EPS came in at $0.08 falling short of the estimated $0.09 by -11.11%, while revenue for the quarter reached $195.25m , missing expectations by -2.49%.
Earnings released on 8 Aug 2024
EPS came in at $0.08 falling short of the estimated $0.09 by -11.11%, while revenue for the quarter reached $200.61m , beating expectations by +0.08%.
Earnings released on 9 May 2024
EPS came in at $0.08 falling short of the estimated $0.09 by -11.11%, while revenue for the quarter reached $197.88m , missing expectations by -1.30%.
Earnings released on 29 Feb 2024
EPS came in at $0.08 matching the estimated $0.08, while revenue for the quarter reached $196.64m , beating expectations by +0.42%.
Earnings released on 9 Nov 2023
EPS came in at $0.06 matching the estimated $0.06, while revenue for the quarter reached $179.96m , missing expectations by -5.68%.
Earnings released on 9 Aug 2023
EPS came in at $0.07 surpassing the estimated $0.06 by +16.67%, while revenue for the quarter reached $189.68m , beating expectations by +1.53%.
Earnings released on 10 May 2023
EPS came in at $0.07 surpassing the estimated $0.06 by +16.67%, while revenue for the quarter reached $183.99m , beating expectations by +1.05%.
Earnings released on 28 Feb 2023
EPS came in at $0.07 surpassing the estimated $0.05 by +40.00%, while revenue for the quarter reached $184.11m , beating expectations by +3.14%.
Earnings released on 8 Nov 2022
EPS came in at $0.07 surpassing the estimated $0.04 by +72.58%, while revenue for the quarter reached $187.32m , beating expectations by +1.23%.
Earnings released on 8 Aug 2022
EPS came in at $0.06 surpassing the estimated $0.04 by +54.36%, while revenue for the quarter reached $191.80m , beating expectations by +3.84%.
Earnings released on 9 May 2022
EPS came in at $0.10 surpassing the estimated $0.08 by +25.00%, while revenue for the quarter reached $203.33m , beating expectations by +1.43%.
Earnings released on 28 Feb 2022
EPS came in at $0.09 falling short of the estimated $0.10 by -10.00%, while revenue for the quarter reached $213.26m , missing expectations by -1.93%.
Earnings released on 10 Nov 2021
EPS came in at $0.09 surpassing the estimated $0.08 by +12.50%, while revenue for the quarter reached $195.10m , missing expectations by -62.96%.
Earnings released on 12 Aug 2021
EPS came in at $0.08 matching the estimated $0.08, while revenue for the quarter reached $176.64m , meeting expectations.
GDRX Stock Performance
Access detailed GDRX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
